Daclizumab
Daclizumab (Zenapax) is a humanized monoclonal antibody that specifically inhibits the alpha subunit of IL-2R-HA. Daclizumab (Zenapax) can inhibit the binding of IL-2 and IL-2R-HA through specific binding to CD25. Daclizumab (Zenapax) studies multiple sclerosis.
Product Specifications
CAS Number
152923-56-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
IL Receptor
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1148244-01 0.02 mg (E-Coli)
Recombinant Escherichia coli Oxidoreductase YdhF (ydhF)
Ask
View Details MBS1148244-02 0.1 mg (E-Coli)
Recombinant Escherichia coli Oxidoreductase YdhF (ydhF)
Ask
View Details 
MBS1148244-03 1 mg (E-Coli)
Recombinant Escherichia coli Oxidoreductase YdhF (ydhF)
Ask
View Details MBS1148244-04 5x 1 mg (E-Coli)
Recombinant Escherichia coli Oxidoreductase YdhF (ydhF)
Ask
View Details